Nuvalent Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	335.39	241.81	68.53	10.33	3.02
Short-Term Investments	384.52	230.36	219.59	0	0
Cash & Cash Equivalents	719.91	472.16	288.11	10.33	3.02
Cash Growth	52.47%	63.88%	2688.53%	242.57%	-
Other Current Assets	6.58	5.83	2.52	0.31	0.3
Total Current Assets	726.49	477.99	290.63	10.65	3.32
Other Long-Term Assets	5.9	4.47	3.2	0	0
Total Long-Term Assets	5.9	4.47	3.2	0	0
Total Assets	732.38	482.46	293.82	10.65	3.32
Accounts Payable	9.27	7.2	2.89	1.25	0.72
Other Current Liabilities	22.55	12.29	5.89	3.13	3.63
Total Current Liabilities	31.82	19.48	8.79	4.38	4.35
Long-Term Debt	0	0	0	2.24	2.17
Total Long-Term Liabilities	0	0	0	2.24	2.17
Total Liabilities	31.82	19.48	8.79	6.62	6.52
Total Debt	0	0	0	2.24	2.17
Debt Growth	-	-	-	2.85%	-
Retained Earnings	-286.3	-160.08	-78.22	-31.89	-17.33
Comprehensive Income	0.03	-0.49	-0.23	0	0
Shareholders' Equity	700.56	462.98	285.04	-31.32	-17.26
Net Cash / Debt	719.91	472.16	288.11	8.1	0.84
Net Cash / Debt Growth	52.47%	63.88%	3458.24%	860.50%	-
Net Cash Per Share	12.36	9.51	13.23	2.82	0.46
Working Capital	694.67	458.51	281.84	6.27	-1.04
Book Value Per Share	12.03	9.32	13.09	-10.93	-9.46

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).